{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-396752","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2026-09-21T20:47:49+00:00","discovered_at":"2026-09-21T20:49:00.451508+00:00","generated_at":"2026-09-21T20:49:10.132851+00:00","sec_items":["3.03","8.01","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Jaguar Health effects 1-for-15 reverse stock split, eliminates 14 preferred series","bullets":["Reverse stock split effective Sept 17, 2026; post-split common shares outstanding approx 520,088.","Filed Certificate of Elimination for 14 series of preferred stock with zero shares outstanding.","All eliminated preferred shares had been converted, exchanged, or disposed of prior to Sept 15, 2026.","Preferred shares returned to authorized but undesignated preferred stock; no impact on common equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-396752","json":"https://secwatch.observer/filing/0001193125-26-396752.json","markdown":"https://secwatch.observer/filing/0001193125-26-396752.md","text":"https://secwatch.observer/filing/0001193125-26-396752.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526396752/0001193125-26-396752-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526396752/d79729d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-21T20:49:10.132851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}